NOV 11, 2015 3:00 PM PST

Proposed Rule for the Medicare Clinical Diagnostic Laboratory Test Payment System

Speaker
  • President, Medical Technology Partners
    Biography
      Jerry Stringham has worked as a reimbursement strategy consultant since the 1980s, when he began providing reimbursement consulting to diverse medical and pharmaceutical companies. Jerry holds a BS in mechanical engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. He has been part of five medical device start-up organizations operating out of New England and has grown MTP's client list to over 140 clients. Jerry founded Medical Technology Partners in 1998 to fill the growing need for business-oriented reimbursement consulting. Jerry's experience in industry, including as a Principal in the health economics practice of a major CRO, brings expertise to new technology reimbursement challenges.

    Abstract

    Medical Technology Partner’s presentation is designed highlight what Medicare is proposing to do based on the Protecting Access to Medicare Act of April 1, 2014 with regard to clinical laboratory diagnostic tests in general and Laboratory Developed Tests in particular.

    This presentation’s learning objectives are to alert participants that there are:

    • Upcoming proposed changes in how Medicare proposes to pay for Clinical Diagnostic Laboratory Tests (CLDTs)
    • Key reimbursement proposals that could affect Laboratory Developed Tests (LDTs)
    • Easy ways to access the CMS source document and respond before  November 24, 2015

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JAN 21, 2021 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    JAN 21, 2021 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    Loading Comments...
    Show Resources